These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Adnot S, Chabrier PE, Andrivet P, Viossat I, Piquet J, Brun-Buisson C, Gutkowska Y, Braquet P. Am Rev Respir Dis; 1987 Oct; 136(4):951-6. PubMed ID: 2959183 [Abstract] [Full Text] [Related]
3. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Nagaya N, Nishikimi T, Uematsu M, Kyotani S, Satoh T, Nakanishi N, Matsuo H, Kangawa K. Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693 [Abstract] [Full Text] [Related]
11. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension. Leskinen H, Vuolteenaho O, Toth M, Ruskoaho H. Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384 [Abstract] [Full Text] [Related]
12. Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia. Jin H, Yang RH, Chen YF, Jackson RM, Oparil S. J Clin Invest; 1990 Jan; 85(1):115-20. PubMed ID: 2136863 [Abstract] [Full Text] [Related]
13. Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats. Jin HK, Yang RH, Thornton RM, Chen YF, Jackson R, Oparil S. J Appl Physiol (1985); 1988 Oct; 65(4):1729-35. PubMed ID: 2972675 [Abstract] [Full Text] [Related]
14. Diagnostic utility of NT-proBNP and ANP in a canine model of chronic embolic pulmonary hypertension. Hori Y, Uchide T, Saitoh R, Thoei D, Uchida M, Yoshioka K, Chikazawa S, Hoshi F. Vet J; 2012 Nov; 194(2):215-21. PubMed ID: 22578688 [Abstract] [Full Text] [Related]
15. Plasma levels of atrial natriuretic peptide under acute hypoxia in normal subjects. Kawashima A, Kubo K, Hirai K, Yoshikawa S, Matsuzawa Y, Kobayashi T. Respir Physiol; 1989 Apr; 76(1):79-91. PubMed ID: 2524868 [Abstract] [Full Text] [Related]
16. Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen. Winter RJ, Davidson AC, Treacher D, Rudd RM, Anderson JV, Meleagros L, Bloom SR. Thorax; 1989 Jan; 44(1):58-62. PubMed ID: 2522688 [Abstract] [Full Text] [Related]
17. Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans. Cargill RI, Lipworth BJ. Br J Clin Pharmacol; 1995 Dec; 40(6):585-90. PubMed ID: 8703666 [Abstract] [Full Text] [Related]
18. Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Kakishita M, Nishikimi T, Okano Y, Satoh T, Kyotani S, Nagaya N, Fukushima K, Nakanishi N, Takishita S, Miyata A, Kangawa K, Matsuo H, Kunieda T. Clin Sci (Lond); 1999 Jan; 96(1):33-9. PubMed ID: 9857104 [Abstract] [Full Text] [Related]
19. Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia. Westendorp RG, Roos AN, van der Hoeven HG, Tjiong MY, Simons R, Frölich M, Souverijn JH, Meinders AE. Am Rev Respir Dis; 1993 Aug; 148(2):304-9. PubMed ID: 8393637 [Abstract] [Full Text] [Related]
20. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Leskinen H, Vuolteenaho O, Leppäluoto J, Ruskoaho H. Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]